The Nebraska Medical Cannabis Commission has given approval to a set of licensing and product regulations for marijuana businesses, following a public meeting held today in Lincoln.
The commission, meeting just days ahead of a July 1 deadline mandated by voters, adopted strict guidelines on what forms of medical marijuana will be allowed once sales begin later this year. Among the most notable decisions: raw plant material, smoked or vaped cannabis products, and infused edibles such as baked goods or beverages will be prohibited.
Instead, the commission approved a narrow list of permitted product types. These include oral tablets, capsules, tinctures, specific gelatinous cubes or lozenges, topical gels or creams, suppositories, transdermal patches, and liquids or oils designed for use with a nebulizer or inhaler. Products containing artificial or natural flavoring or coloring are also banned under the new rules.
The regulations were approved as emergency regulations during a public meeting at the Nebraska State Office Building in Lincoln, which comes roughly three weeks after the commission’s inaugural session. Members faced a compressed timeline due to the passage of Initiative 437 and Initiative 438 in November, which legalized medical marijuana and created the commission tasked with overseeing its regulation.
Initiative 437 allows qualified patients to legally possess up to five ounces of marijuana for medical use. Initiative 438 set July 1 as the deadline for rulemaking, with business licenses required to begin issuing by October 1.
The commission also approved a strict set of rules for those wanting to operate a licensed cannabis business. The full 19-page set of regulations can be found by clicking here, courtesy of the Nebraska Examiner.
More articles from The Marijuana Herald can be found below.
